XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
MLKN MillerKnoll
- 22.730
- +0.180+0.80%
Close Feb 14 16:00 ET
- 22.730
- 0.0000.00%
Post 20:01 ET
1.55BMarket Cap24.98P/E (TTM)
23.120High22.590Low259.62KVolume22.770Open22.550Pre Close5.90MTurnover0.39%Turnover Ratio20.48P/E (Static)68.16MShares31.29452wk High1.18P/B1.53BFloat Cap20.89052wk Low0.75Dividend TTM67.21MShs Float46.269Historical High3.30%Div YieldTTM2.35%Amplitude5.976Historical Low22.726Avg Price1Lot Size
MillerKnoll Key Stats
Quarterly+Annual
YOY
| (Q2)Nov 30, 2024 | (Q1)Aug 31, 2024 | (FY)Jun 1, 2024 | (Q4)Jun 1, 2024 | (Q3)Mar 2, 2024 | (Q2)Dec 2, 2023 | (Q1)Sep 2, 2023 | (FY)Jun 3, 2023 | (Q4)Jun 3, 2023 | (Q3)Mar 4, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.20%970.4M | -6.12%861.5M | -11.22%3.63B | -7.09%888.9M | -11.41%872.3M | -11.00%949.5M | -14.93%917.7M | 3.58%4.09B | -13.07%956.7M | 984.7M |
| Operating revenue | 2.30%969M | -6.15%858.9M | -11.22%3.63B | -7.28%896.4M | -11.39%869.6M | -10.94%947.2M | -14.90%915.2M | 3.58%4.09B | -12.81%966.8M | --981.4M |
| Cost of revenue | 2.75%593.4M | -6.15%525.2M | -16.87%2.21B | -10.88%536.5M | -17.53%535.3M | -17.42%577.5M | -20.82%559.6M | 2.46%2.66B | -16.16%602M | 649.1M |
| Gross profit | 1.34%377M | -6.09%336.3M | -0.73%1.42B | -0.65%352.4M | 0.42%337M | 1.20%372M | -3.76%358.1M | 5.71%1.43B | -7.27%354.7M | 335.6M |
| Operating expense | 1.52%314.5M | 2.72%321.1M | -2.22%1.2B | -6.15%289.8M | 1.46%292.5M | -1.40%309.8M | -2.56%312.6M | -6.15%1.23B | -5.13%308.8M | 288.3M |
| Selling and administrative expenses | 0.80%289.9M | 2.72%298.4M | -1.27%1.11B | -4.09%262.9M | 2.42%271.1M | -1.10%287.6M | -2.16%290.5M | -6.46%1.13B | -7.52%274.1M | --264.7M |
| Research and development costs | 10.81%24.6M | 2.71%22.7M | -12.39%92.6M | -22.48%26.9M | -9.32%21.4M | -5.13%22.2M | -7.53%22.1M | -2.76%105.7M | 19.24%34.7M | --23.6M |
| Operating profit | 0.48%62.5M | -66.59%15.2M | 8.54%214.8M | 36.38%62.6M | -5.92%44.5M | 16.48%62.2M | -11.31%45.5M | 397.24%197.9M | -19.47%45.9M | 47.3M |
| Net non-operating interest income expense | -2.16%-18.9M | -7.65%-18.3M | 1.54%-70.1M | 8.38%-17.5M | 6.04%-17.1M | -5.11%-18.5M | -4.29%-17M | -96.69%-71.2M | -52.80%-19.1M | -18.2M |
| Non-operating interest income | 15.38%1.5M | -27.27%1.6M | 117.86%6.1M | 62.50%1.3M | 44.44%1.3M | 85.71%1.3M | 450.00%2.2M | 75.00%2.8M | 100.00%800K | --900K |
| Non-operating interest expense | 3.03%20.4M | 3.65%19.9M | 2.97%76.2M | -5.53%18.8M | -3.66%18.4M | 8.20%19.8M | 14.97%19.2M | 95.77%74M | 54.26%19.9M | --19.1M |
| Other net income (expense) | 116.67%1.3M | 118.92%1.4M | 40.24%-45M | -18.58%-38.3M | 100.36%100K | 104.23%600K | -469.23%-7.4M | -517.21%-75.3M | -10,666.67%-32.3M | -27.5M |
| Special income (charges) | --0 | --0 | 37.04%-47.6M | -13.41%-38.9M | 93.49%-1.7M | 87.76%-1.8M | -940.00%-5.2M | ---75.6M | ---34.3M | ---26.1M |
| -Less：Restructuring and merger&acquisition | --0 | --0 | -10.47%30.8M | 51.37%22.1M | -63.04%1.7M | -87.76%1.8M | 940.00%5.2M | --34.4M | --14.6M | --4.6M |
| -Less:Impairment of capital assets | ---- | ---- | -59.22%16.8M | -14.72%16.8M | --0 | ---- | ---- | --41.2M | --19.7M | --21.5M |
| Other non- operating income (expenses) | -45.83%1.3M | 163.64%1.4M | 766.67%2.6M | -70.00%600K | 228.57%1.8M | 380.00%2.4M | -175.00%-2.2M | 102.46%300K | 766.67%2M | ---1.4M |
| Income before tax | 1.35%44.9M | -108.06%-1.7M | 93.97%99.7M | 223.64%6.8M | 1,618.75%27.5M | 105.09%44.3M | -37.39%21.1M | 697.67%51.4M | -112.44%-5.5M | 1.6M |
| Income tax | 3.16%9.8M | -121.57%-1.1M | 226.67%14.7M | 34.85%-4.3M | 780.00%4.4M | 120.93%9.5M | -19.05%5.1M | -59.46%4.5M | -131.58%-6.6M | 500K |
| Earnings from equity interest net of tax | 125.00%100K | 0.00%100K | 50.00%-400K | 90.00%-100K | --0 | -300.00%-400K | --100K | ---800K | ---1M | --0 |
| Net income | 2.33%35.2M | -103.11%-500K | 83.51%84.6M | 10,900.00%11M | 2,000.00%23.1M | 96.57%34.4M | -41.24%16.1M | 334.01%46.1M | -99.57%100K | 1.1M |
| Net income continuous Operations | 2.33%35.2M | -103.11%-500K | 83.51%84.6M | 10,900.00%11M | 2,000.00%23.1M | 96.57%34.4M | -41.24%16.1M | 334.01%46.1M | -99.57%100K | --1.1M |
| Minority interest income | 22.22%1.1M | 216.67%700K | -42.50%2.3M | 450.00%1.1M | 28.57%900K | -40.00%900K | -137.50%-600K | -45.95%4M | -88.24%200K | 700K |
| Net income attributable to the parent company | 1.79%34.1M | -107.19%-1.2M | 95.49%82.3M | 10,000.00%9.9M | 5,450.00%22.2M | 109.38%33.5M | -35.27%16.7M | 255.35%42.1M | -100.46%-100K | 400K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 1.79%34.1M | -107.19%-1.2M | 95.49%82.3M | 10,000.00%9.9M | 5,450.00%22.2M | 109.38%33.5M | -35.27%16.7M | 255.35%42.1M | -100.46%-100K | 400K |
| Basic earnings per share | 8.89%0.49 | -109.09%-0.02 | 100.00%1.12 | 10,682.01%0.14 | 3,000.00%0.31 | 114.29%0.45 | -35.29%0.22 | 251.35%0.56 | -100.47%-0.0013 | 0.01 |
| Diluted earnings per share | 8.89%0.49 | -109.09%-0.02 | 101.82%1.11 | 10,682.01%0.14 | 2,900.00%0.3 | 114.29%0.45 | -35.29%0.22 | 248.65%0.55 | -100.47%-0.0013 | 0.01 |
| Dividend per share | 0.00%0.1875 | 0.00%0.1875 | 0.00%0.75 | 0.00%0.1875 | 0.00%0.1875 | 0.00%0.1875 | 0.00%0.1875 | 0.00%0.75 | 0.00%0.1875 | 0.1875 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Trending Stocks
Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1
Popular on moomoo
Feb 13 17:34
China's asset revaluation sparks debate: What are mooers buying?